{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-011569","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2026-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.925479+00:00","generated_at":"2026-05-15T08:34:35.925340+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ADMA Biologics refutes Culper Research short seller allegations; provides inventory & demand data","bullets":["Demand for ASCENIV growing; end-user demand increased past two years; current days on hand average 90 days as of March 22, 2026.","Refutes channel stuffing; says distributor inventory levels consistent with industry standards; average days on hand above safety stock: 48 days for ASCENIV, 51 days for BIVIGAM as of March 22.","ASCENIV positioned as late-line therapy for immune compromised patients who fail standard IG; premium pricing; new IVIG launches not competitive threat.","ADMA received unqualified audit opinions from Big Four firm for FY2024 and FY2025; prior auditor resigned due to acquisition.","No undisclosed related party transactions; no Grossman-family entity distributed or took title to any ADMA products."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-011569","json":"https://secwatch.observer/filing/0001140361-26-011569.json","markdown":"https://secwatch.observer/filing/0001140361-26-011569.md","text":"https://secwatch.observer/filing/0001140361-26-011569.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126011569/0001140361-26-011569-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126011569/ef20069109_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:34:35.925340+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}